Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-08 Purchase |
2023-12-11 4:30 pm |
Generation Bio Co. | GBIO | Appelhans Dannielle Director |
8,000 | $1.7924 | $14,339 | 20,000 (Indirect Direct) |
View |
| 2023-12-04 Purchase |
2023-12-06 4:30 pm |
Generation Bio Co. | GBIO | Appelhans Dannielle Director |
12,000 | $1.5 | $18,000 | 12,000 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 6:08 pm |
Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle CEO and President |
10,385 | $0.1274 | $1,323 | 0 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-01 9:40 pm |
Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle CEO and President |
3,878 | $0.25 | $970 | 32,885 (Direct) |
View |
| 2022-08-10 Sale |
2022-08-12 3:06 pm |
Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer |
5,737 | $0.8 | $4,590 | 44,263 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-06 Option Award |
2024-06-10 4:05 pm |
N/A 2034-06-05 |
Generation Bio Co. | GBIO | Appelhans Dannielle Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:15 pm |
N/A 2033-06-07 |
Generation Bio Co. | GBIO | Appelhans Dannielle Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-01-31 Exercise |
2023-02-01 9:40 pm |
N/A N/A |
Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle CEO and President |
7,500 | $0 | 32,885 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-12 3:06 pm |
N/A N/A |
Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer |
12,500 | $0 | 44,263 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:07 pm |
N/A 2032-07-14 |
Generation Bio Co. | GBIO | Appelhans Dannielle Director |
38,400 | $0 | 38,400 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 9:19 pm |
N/A 2032-01-30 |
Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer |
155,000 | $0 | 155,000 (Direct) |
View |
| 2021-08-31 Option Award |
2021-09-01 8:12 pm |
N/A 2031-08-30 |
Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer |
200,000 | $0 | 200,000 (Direct) |
View |